<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04730726</url>
  </required_header>
  <id_info>
    <org_study_id>201900301</org_study_id>
    <nct_id>NCT04730726</nct_id>
  </id_info>
  <brief_title>In Vivo Multispectral Optoacoustic Imaging of Thyroid Nodules</brief_title>
  <acronym>THYNODE</acronym>
  <official_title>In Vivo Multispectral Optoacoustic Imaging of Thyroid Nodules</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Center Groningen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Center Groningen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thyroid nodules are common in clinical practice. Head and neck ultrasound is recommended as a&#xD;
      routine examination for all patients with thyroid lesions. The Thyroid Imaging Reporting And&#xD;
      Documentation System (TIRADS) criteria helps to estimate the risk of malignancy based on&#xD;
      ultrasound patterns and nodule sizes guiding the performance of fine-needle-aspiration (FNA).&#xD;
      Approximately 20% of FNA results cannot be specified whether being benign or malig-nant&#xD;
      tissue. A definitive diagnosis can only be made from histopathology after diagnostic&#xD;
      (hemi)thyroidectomy. However, (hemi)thyroidectomy has disadvantages as it leads to&#xD;
      over-treatment and has a risk of postoperative morbidity (e.g. hypothyroidism and laryngeal&#xD;
      nerve injury). Furthermore, (hemi)thyroidectomy is known to be associated with poor quality&#xD;
      of life. Clearly, there is an unmet need for additional diagnostic tools in order to identify&#xD;
      malignant thyroid nodules and thereby support the decision making for treatment of the&#xD;
      thyroid.&#xD;
&#xD;
      Multispectral optoacoustic tomography (MSOT) is an innovative, non-invasive imaging method&#xD;
      currently available in the UMCG that enables visualization of endogenous chromophores and&#xD;
      exogenous contrast agents using the generation of ultrasound waves due to light absorption by&#xD;
      using high frequency pulsed laser light. Recently, this system has been used by other groups&#xD;
      for non-invasive determination of thyroid nodules. Results show that multispectral&#xD;
      optoacoustic imaging of thyroid nodules may distinguish benign from malignant nodules.&#xD;
      However, most certainly, a larger cohort is necessary to confirm this finding.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MSOT signals of endogenous biomarkers</measure>
    <time_frame>2 years</time_frame>
    <description>HbO2, HbR, HbT, sO2, fat, water and collagen</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Potential correlation FNA</measure>
    <time_frame>2 years</time_frame>
    <description>To explore a potential correlation between endogenous optoacoustic signals in vivo with cytology (the standard-of-care of Bethesda scoring system derived from FNA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Potential correlation ultrasound</measure>
    <time_frame>2 years</time_frame>
    <description>To explore a potential correlation between endogenous optoacoustic signals in vivo with TIRADS ultrasonography scoring system (the scoring system used by radiologists when evaluating the thyroid nodules with ultrasonography).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Thyroid Nodule</condition>
  <arm_group>
    <arm_group_label>Patients with thyroid nodules</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with thyroid nodules that underwent or will undergo an ultrasound with FNA if indicated and if indicated will be scheduled for a (hemi)thyroidectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MSOT Acuity Echo</intervention_name>
    <description>Hybrid optoacoustic and ultrasonography imaging</description>
    <arm_group_label>Patients with thyroid nodules</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients with thyroid nodules who underwent or will undergo an ultrasonography (with&#xD;
             TIRADS score) with FNA if indicated and will be scheduled for a (hemi)thyroidectomy if&#xD;
             indicated;&#xD;
&#xD;
          2. Age â‰¥ 18 years;&#xD;
&#xD;
          3. Written informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Medical or psychiatric conditions that compromise the patients' ability to give&#xD;
             informed consent;&#xD;
&#xD;
          2. Previous surgery in head and neck area&#xD;
&#xD;
          3. Previous radiotherapy in head and neck area&#xD;
&#xD;
          4. Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9713GZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Schelto Kruijff, MD, PhD</last_name>
      <phone>0031503612317</phone>
      <email>s.kruijff@umcg.nl</email>
    </contact>
    <investigator>
      <last_name>Schelto Kruijff, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 26, 2021</study_first_submitted>
  <study_first_submitted_qc>January 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2021</study_first_posted>
  <last_update_submitted>January 26, 2021</last_update_submitted>
  <last_update_submitted_qc>January 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Center Groningen</investigator_affiliation>
    <investigator_full_name>Schelto Kruijff, MD PhD</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Nodule</mesh_term>
    <mesh_term>Thyroid Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

